Current FDA oversight of vaping industry is likely to have minimal impact

Experiencing symptoms of COVID-19 is associated with poorer mental health
13 October 2022
Live births in Europe decreased by 14% nine months after start of COVID-19 pandemic and first lockdowns
14 October 2022

Current FDA oversight of vaping industry is likely to have minimal impact

Current Food and Drug Administration (FDA) oversight of the vaping industry in the U.S. is likely to have minimal impact, suggests an analysis of the regulator’s warning letters for marketing violations, published online in the journal Tobacco Control.

Comments are closed.